{
    "status": "ok",
    "totalResults": 133,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "Nakedcapitalism.com"
            },
            "author": "Lambert Strether",
            "title": "Loper Bright Enterprises v. Raimondo: A Conservative Assault on the Administrative State",
            "description": "Loper Bright Enterprises v. Raimondo is an even bigger case than United States v. Google, Inc.",
            "url": "https://www.nakedcapitalism.com/2023/09/loper-bright-enterprises-v-raimondo-a-conservative-assault-on-the-administrative-state.html",
            "urlToImage": "https://www.nakedcapitalism.com/wp-content/uploads/2023/09/rule-making.png",
            "publishedAt": "2023-09-25T19:25:11Z",
            "content": "By Lambert Strether of Corrente.\r\nLoper Bright Enterprises v. Raimondo (Loper), to be decided in this Supreme Court term, is an even bigger case than United States v. Google Inc (Google). Google has \u2026 [+25509 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Yahoo Entertainment"
            },
            "author": "Affan Mir",
            "title": "50 Most Famous American Investors",
            "description": "In this article, we discuss the 50 most famous American investors. To skip our analysis of ultra-high net worth individuals\u2019 investment portfolios and the...",
            "url": "https://finance.yahoo.com/news/50-most-famous-american-investors-180033782.html",
            "urlToImage": "https://s.yimg.com/ny/api/res/1.2/NPa_p6retMp5237.fx9J3g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0xNjIx/https://media.zenfs.com/en/insidermonkey.com/8a873e0e0e1d9b622c25d2359760e1c7",
            "publishedAt": "2023-09-22T18:00:33Z",
            "content": "In this article, we discuss the 50 most famous American investors. To skip our analysis of ultra-high net worth individuals investment portfolios and the hedge fund industry, go directly to the 10 Mo\u2026 [+22514 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Business Wire",
            "title": "United Therapeutics Announces Recent Milestones for its Heart and Kidney Xenotransplantation Programs",
            "description": "(marketscreener.com) \nSecond UHeart\u2122 recipient recovering after a successful transplant\n\n\nUThymoKidney\u2122 demonstrates normal function during a 61-day study\n\n\nHuman xenotransplant clinical studies could begin in 2025\n\nhttps://www.marketscreener.com/quote/stock/\u2026",
            "url": "https://www.marketscreener.com/quote/stock/UNITED-THERAPEUTICS-CORPO-11262/news/United-Therapeutics-Announces-Recent-Milestones-for-its-Heart-and-Kidney-Xenotransplantation-Program-44907197/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-09-22T18:16:01Z",
            "content": "Second UHeart recipient recovering after a successful transplant\r\nUThymoKidney demonstrates normal function during a 61-day study\r\nHuman xenotransplant clinical studies could begin in 2025\r\nUnited Th\u2026 [+9002 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Brainy Insights Pvt. Ltd.",
            "title": "[Latest] Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Envisioned at USD 2588.23 Million by 2030, Increasing a CAGR of 10.62% | Rising Investments by Pharmaceutical Giants",
            "description": "[230 + Pages Report] According to a market research study published by The Brainy Insights, the demand analysis of Global Acute Myeloid Leukemia (AML) Therapeutics Market size & share revenue was valued at around USD 1043.52 million in 2021 and is estimated t\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/27/2750794/0/en/Latest-Global-Acute-Myeloid-Leukemia-AML-Therapeutics-Market-Size-Envisioned-at-USD-2588-23-Million-by-2030-Increasing-a-CAGR-of-10-62-Rising-Investments-by-Pharmaceutical-Giants.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/e0ed2f75-5061-4c4a-a30b-65427e5cc0f4",
            "publishedAt": "2023-09-27T22:00:00Z",
            "content": "Newark, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The global\u00a0acute myeloid leukemia (AML) therapeutics market is expected to grow from 1043.52 million in 2021 to USD 2588.23 million, at a CAGR of 10.62% dur\u2026 [+7082 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Publicnow",
            "title": "Rapid Dose Therapeutics : Closing of Second Tranche of Private Placement Financing, Amendment to Terms of Secured Debt and Director Change",
            "description": "(marketscreener.com) \n \n Press Releases\n \n \n \n Press Release\n \n \n \n \n \n Closing of Second Tranche of Private Placement Financing, Amendment to Terms of Secured Debt and Director Change\n \n \n September 22, 2023\n \n \n \n Corporate Update\n...https://www.marketscree\u2026",
            "url": "https://www.marketscreener.com/quote/stock/RAPID-DOSE-THERAPEUTICS-C-49518135/news/Rapid-Dose-Therapeutics-Closing-of-Second-Tranche-of-Private-Placement-Financing-Amendment-to-Ter-44908053/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-09-22T21:34:02Z",
            "content": "Corporate Update\r\nBURLINGTON, Ontario - September 22, 2023 - Rapid Dose Therapeutics Corp. (\"RDT\" or the \"Company\") (CSE: DOSE) is pleased to announce that it has closed on $310,000 in a second tranc\u2026 [+11151 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "DelveInsight Business Research LLP",
            "title": "Presbyopia Market to Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies - Eyenovia, Orasis, Ocuphire Pharma, Visus Therapeutics, LENZ Therapeutics, Glaukos Corporation, AbbVie",
            "description": "The presbyopia market is predicted to grow during the forecast period (2023\u20132032) owing to the development of well-designed, randomized trials to study novel drugs with potential benefits for Presbyopia patients, the shortfall of approved therapy, and the lau\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/14/2743582/0/en/Presbyopia-Market-to-Exhibit-Significant-Growth-by-2032-Predicts-DelveInsight-Key-Companies-Eyenovia-Orasis-Ocuphire-Pharma-Visus-Therapeutics-LENZ-Therapeutics-Glaukos-Corporation.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db",
            "publishedAt": "2023-09-14T17:00:00Z",
            "content": "New York, USA, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Presbyopia Market to Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies - Eyenovia, Orasis, Ocuphire Pharma, Visus Therapeutic\u2026 [+17283 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Knight Therapeutics Announces Regulatory Submission of Pemigatinib in Brazil",
            "description": "(marketscreener.com) MONTREAL, Oct. 10, 2023 -- Knight Therapeutics Inc., a pan-American specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltd., has submitted a marketing authorization application for pemigatinib t\u2026",
            "url": "https://www.marketscreener.com/quote/stock/KNIGHT-THERAPEUTICS-INC-15925497/news/Knight-Therapeutics-Announces-Regulatory-Submission-of-Pemigatinib-in-Brazil-45032793/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-10-10T20:46:02Z",
            "content": "MONTREAL, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) (\"Knight\") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, Uni\u2026 [+9215 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "DataHorizzon Research",
            "title": "Cell Culture Market To Reach USD 63.1 Billion By 2032, Says DataHorizzon Research",
            "description": "Comprehensive analysis of cell culture market report. Ongoing research and development in medical research encourage the development of novel therapeutics. Comprehensive analysis of cell culture market report. Ongoing research and development in medical resea\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/11/2758474/0/en/Cell-Culture-Market-To-Reach-USD-63-1-Billion-By-2032-Says-DataHorizzon-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/ee0903f0-279f-4537-8a89-666461d3d324",
            "publishedAt": "2023-10-11T13:30:00Z",
            "content": "Fort Collins, Colorado, Oct. 11, 2023 (GLOBE NEWSWIRE) -- According to DataHorizzon Research, the\u00a0cell culture market size was valued at USD 24.1 Billion in 2022 and is expected to arrive at a market\u2026 [+5390 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Business Wire",
            "title": "Rule 17(e) Announcement - Horizon Therapeutics plc",
            "description": "(marketscreener.com) \n\u00a0\n\n\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION\n\n\nFOR I\u2026",
            "url": "https://www.marketscreener.com/quote/stock/HORIZON-THERAPEUTICS-PUBL-18100076/news/Rule-17-e-Announcement-Horizon-Therapeutics-plc-45001367/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-10-06T12:31:02Z",
            "content": "NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULA\u2026 [+3969 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Knight Therapeutics",
            "title": "Knight Therapeutics Announces Regulatory Submission of Pemigatinib in Brazil",
            "description": "MONTREAL, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) (\"Knight\") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltd., has submitted a marketing authorization ap\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/10/2757944/0/en/Knight-Therapeutics-Announces-Regulatory-Submission-of-Pemigatinib-in-Brazil.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/e9457092-692d-4bfd-b361-9799ee8d73cd",
            "publishedAt": "2023-10-10T20:45:00Z",
            "content": "MONTREAL, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) (\"Knight\") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, Uni\u2026 [+8703 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "DelveInsight Business Research LLP",
            "title": "Sjogren's Syndrome Market Size Increase with Significant CAGR by 2032, Predicts DelveInsight | Key Companies in the Market - Resolve, MorphoSys, Novartis, GlaxoSmithKline, Roche, BMS, TearSolutions, Incyte, Galapagos, Gilead Sciences",
            "description": "Sjogren's syndrome market dynamics are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness of the disease, incremental healthcare spending worldwide, and the expected launch of emerging therapies\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/21/2747580/0/en/Sjogren-s-Syndrome-Market-Size-Increase-with-Significant-CAGR-by-2032-Predicts-DelveInsight-Key-Companies-in-the-Market-Resolve-MorphoSys-Novartis-GlaxoSmithKline-Roche-BMS-TearSol.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db",
            "publishedAt": "2023-09-21T17:00:00Z",
            "content": "New York, USA, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Sjogren's Syndrome Market Size Increase with Significant CAGR by 2032, Predicts DelveInsight | Key Companies in the Market - Resolve, MorphoSys, Nova\u2026 [+19305 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "DelveInsight Business Research LLP",
            "title": "Warm Autoimmune Hemolytic Anemia Market is Predicted to Exhibit Remarkable Growth by 2032, Analyzes DelveInsight | Leading Companies - Zenas BioPharma, Sanofi, Johnson & Johnson, Novartis, Incyte, Rigel, Alpine Immune Sciences, Hutchison",
            "description": "The dynamics of the warm autoimmune hemolytic anemia market are anticipated to change in the coming years owing to the rise in demand for the development of combination therapies and anemia therapeutics in patient assistance programs is also expected to drive\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/26/2749877/0/en/Warm-Autoimmune-Hemolytic-Anemia-Market-is-Predicted-to-Exhibit-Remarkable-Growth-by-2032-Analyzes-DelveInsight-Leading-Companies-Zenas-BioPharma-Sanofi-Johnson-Johnson-Novartis-In.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db",
            "publishedAt": "2023-09-26T17:00:00Z",
            "content": "New York, USA, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Warm Autoimmune Hemolytic Anemia Market is Predicted to Exhibit Remarkable Growth by 2032, Analyzes DelveInsight | Leading Companies - Zenas BioPharm\u2026 [+15897 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Global Pharmacovigilance Market, 2023-2030: Oncology Therapeutics Lead the Charge in Pharmacovigilance Efforts",
            "description": "Dublin, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The \"Pharmacovigilance Market Size, Share & Trends Analysis Report By Service Provider (In-house, Contract Outsourcing), By Product Life Cycle, By Therapeutic Area, By Process Flow, By End-Use, By Type, And Segment F\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/22/2747889/28124/en/Global-Pharmacovigilance-Market-2023-2030-Oncology-Therapeutics-Lead-the-Charge-in-Pharmacovigilance-Efforts.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-09-22T11:03:00Z",
            "content": "Dublin, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The \"Pharmacovigilance Market Size, Share &amp; Trends Analysis Report By Service Provider (In-house, Contract Outsourcing), By Product Life Cycle, By Thera\u2026 [+5104 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Zevra Therapeutics",
            "title": "Zevra Therapeutics Appoints Neil F. McFarlane as President, Chief Executive Officer and Director",
            "description": "Zevra Therapeutics Appoints Neil F. McFarlane as President, Chief Executive Officer and Director......",
            "url": "https://www.globenewswire.com/news-release/2023/10/10/2757355/16626/en/Zevra-Therapeutics-Appoints-Neil-F-McFarlane-as-President-Chief-Executive-Officer-and-Director.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/cf39ab90-8c07-407d-a7ea-b7c9d48d44c4",
            "publishedAt": "2023-10-10T11:30:00Z",
            "content": "Christal Mickle transitions back to Chief Development Officer\r\nCELEBRATION, Fla., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease t\u2026 [+8261 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "GlobeNewswire",
            "title": "FDA Accepts Submission to Add PH-ILD to YUTREPIA\u2122 Label",
            "description": "(marketscreener.com) Sets PDUFA goal date of January 24, 2024If approved, YUTREPIA would be indicated for treatment of both PAH and PH-ILD MORRISVILLE, N.C., Sept. 25, 2023 -- Liquidia Corporation announced today that the U.S. Food and Drug Administration acc\u2026",
            "url": "https://www.marketscreener.com/quote/stock/LIQUIDIA-CORPORATION-45064777/news/FDA-Accepts-Submission-to-Add-PH-ILD-to-YUTREPIA-trade-Label-44917370/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-09-25T20:10:01Z",
            "content": "<ul><li>Sets PDUFA goal date of January 24, 2024</li><li>If approved, YUTREPIA would be indicated for treatment of both PAH and PH-ILD</li></ul>MORRISVILLE, N.C., Sept. 25, 2023 (GLOBE NEWSWIRE) -- L\u2026 [+8409 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "DelveInsight Business Research LLP",
            "title": "IgA Nephropathy Market to Exhibit Growth at a Tremendous CAGR of ~20% by 2032 | DelveInsight",
            "description": "As potential therapies with novel mechanisms are being investigated to improve the management of IgAN, it is safe to predict that the IgA nephropathy market space will experience significant growth during the forecast period (2023\u20132032). However, the challeng\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/03/2754025/0/en/IgA-Nephropathy-Market-to-Exhibit-Growth-at-a-Tremendous-CAGR-of-20-by-2032-DelveInsight.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db",
            "publishedAt": "2023-10-03T17:00:00Z",
            "content": "New York, USA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- IgA Nephropathy Market to Exhibit Growth at a Tremendous CAGR of ~20% by 2032 | DelveInsight\r\nAs potential therapies with novel mechanisms are being i\u2026 [+16848 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Global Nonalcoholic Steatohepatitis (NASH) Therapeutics Market 2023-2035: Key Players Pfizer, Novo Nordisk, and Galmed Pharmaceuticals Drive Innovation in the NASH Therapeutics Market",
            "description": "Dublin, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The \"Global Nonalcoholic Steatohepatitis (NASH) Therapeutics Market Outlook to 2035\" report has been added to ResearchAndMarkets.com's offering.",
            "url": "https://www.globenewswire.com/news-release/2023/09/28/2751006/28124/en/Global-Nonalcoholic-Steatohepatitis-NASH-Therapeutics-Market-2023-2035-Key-Players-Pfizer-Novo-Nordisk-and-Galmed-Pharmaceuticals-Drive-Innovation-in-the-NASH-Therapeutics-Market.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-09-28T10:03:00Z",
            "content": "Dublin, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The \"Global Nonalcoholic Steatohepatitis (NASH) Therapeutics Market Outlook to 2035\" report has been added to ResearchAndMarkets.com's offering.\r\nThe global\u2026 [+3027 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "DelveInsight Business Research LLP",
            "title": "Marginal Zone Lymphoma Market Size Expected to Demonstrate Optimal Growth in the 7MM During the Study Period (2019\u20132032), Analysis by DelveInsight",
            "description": "The marginal zone lymphoma pipeline possesses potential drugs in mid-stage developments to be launched in the near future. The total marginal zone lymphoma market is categorized into three types based on the line of therapies, i.e., first-line, second-line, a\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/12/2759573/0/en/Marginal-Zone-Lymphoma-Market-Size-Expected-to-Demonstrate-Optimal-Growth-in-the-7MM-During-the-Study-Period-2019-2032-Analysis-by-DelveInsight.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db",
            "publishedAt": "2023-10-12T17:00:00Z",
            "content": "New York, USA, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Marginal Zone Lymphoma Market Size Expected to Demonstrate Optimal Growth in the 7MM During the Study Period (20192032), Analysis by DelveInsight\u00a0\r\nTh\u2026 [+19284 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Business Wire",
            "title": "Rule 17(d) Announcement \u2013 Horizon Therapeutics plc",
            "description": "(marketscreener.com) \n\u00a0\n\n\nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION\n\n\nOctob\u2026",
            "url": "https://www.marketscreener.com/quote/stock/HORIZON-THERAPEUTICS-PUBL-18100076/news/Rule-17-d-Announcement-ndash-Horizon-Therapeutics-plc-44991673/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-10-05T11:41:01Z",
            "content": "NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULA\u2026 [+7124 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PR Newswire UK"
            },
            "author": null,
            "title": "Asthma Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight | Key Companies to Look Out - GlaxoSmithKline, AstraZeneca, Sanofi, Roche, Amgen, Regeneron, Incyte, Areteia, Suzhou Connect, Cumberland, Pulmatrix",
            "description": "The asthma market will boost during the forecast period (2023\u20132032) due to improvement in diagnosis over the globe and thus the surge in treatment options along with the expected launch of emerging therapies, for asthma treatment. LAS VEGAS, Sept. 14, 2023 /P\u2026",
            "url": "https://www.prnewswire.co.uk/news-releases/asthma-market-is-predicted-to-exhibit-remarkable-growth-by-2032-predicts-delveinsight--key-companies-to-look-out---glaxosmithkline-astrazeneca-sanofi-roche-amgen-regeneron-incyte-areteia-suzhou-connect-cumberland-pulma-301927414.html",
            "urlToImage": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-14T21:01:00Z",
            "content": "The asthma market will boost during the forecast period (20232032) due to improvement in diagnosis over the globe and thus the surge in treatment options along with the expected launch of emerging th\u2026 [+14113 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "DelveInsight Business Research LLP",
            "title": "Charcot-Marie-Tooth Disease Market Size and Share to Grow by 2032, Predicts DelveInsight | Key Players in the Market - Pharnext, MedDay, HELIXMITH, ENCell, InFlectis, Addex, Augustine, DTx Pharma",
            "description": "The increase in the Charcot-Marie-Tooth disease market size is a direct consequence of increasing prevalent population of Charcot-Marie-Tooth disease patients in the 7MM. The increase in the Charcot-Marie-Tooth disease market size is a direct consequence of i\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/18/2745135/0/en/Charcot-Marie-Tooth-Disease-Market-Size-and-Share-to-Grow-by-2032-Predicts-DelveInsight-Key-Players-in-the-Market-Pharnext-MedDay-HELIXMITH-ENCell-InFlectis-Addex-Augustine-DTx-Pha.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db",
            "publishedAt": "2023-09-18T17:00:00Z",
            "content": "New York, USA, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Charcot-Marie-Tooth Disease Market Size and Share to Grow by 2032, Predicts DelveInsight | Key Players in the Market - Pharnext, MedDay, HELIXMITH, E\u2026 [+17202 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "DelveInsight Business Research LLP",
            "title": "Musculoskeletal Pain Market Set to Observe Remunerative Growth During the Study Period (2019-2032) | DelveInsight",
            "description": "The emergence of new products in the pipeline will add to the musculoskeletal pain market growth in the future. In addition, persistently rising cases of chronic pain in the forecast period will help increase the musculoskeletal pain treatment market. The eme\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/10/2757825/0/en/Musculoskeletal-Pain-Market-Set-to-Observe-Remunerative-Growth-During-the-Study-Period-2019-2032-DelveInsight.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db",
            "publishedAt": "2023-10-10T17:00:00Z",
            "content": "New York, USA, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Musculoskeletal Pain Market Set to Observe Remunerative Growth During the Study Period (2019-2032) | DelveInsight\u00a0\r\nThe emergence of new products in t\u2026 [+20812 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Arbutus Announces Multiple Abstracts Accepted for Presentation at AASLD - The Liver Meeting\u00ae 2023",
            "description": "(marketscreener.com) Imdusiran data will be highlighted in late breaking presentation WARMINSTER, Pa., Oct. 11, 2023 -- Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel the\u2026",
            "url": "https://www.marketscreener.com/quote/stock/ARBUTUS-BIOPHARMA-CORPORA-23319313/news/Arbutus-Announces-Multiple-Abstracts-Accepted-for-Presentation-at-AASLD-The-Liver-Meeting-2023-45039583/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-10-11T12:06:02Z",
            "content": "Imdusiran data will be highlighted in late breaking presentation\r\nWARMINSTER, Pa., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical c\u2026 [+12699 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PR Newswire UK"
            },
            "author": null,
            "title": "Open-Angle Glaucoma Market Size and Share to Accelerate Substantially by 2032, Predicts DelveInsight | Key Companies in the Market - SPARC, AbbVie, Ocuphire, Santen, Glaukos, Ocular Therapeutix, VivaVision Biotech, MediPrint Ophthalmics",
            "description": "According to DelveInsight's' estimates, the open-angle glaucoma market in the 7MM is expected to show positive growth, during the forecast period (2023\u20132032), mainly attributed to the launch of upcoming therapies and the increasing prevalence of open-angle gl\u2026",
            "url": "https://www.prnewswire.co.uk/news-releases/open-angle-glaucoma-market-size-and-share-to-accelerate-substantially-by-2032-predicts-delveinsight--key-companies-in-the-market---sparc-abbvie-ocuphire-santen-glaukos-ocular-therapeutix-vivavision-biotech-mediprint-ophth-301954534.html",
            "urlToImage": "https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg?p=facebook",
            "publishedAt": "2023-10-12T21:01:00Z",
            "content": "According to DelveInsight's' estimates, the open-angle glaucoma market in the 7MM is expected to show positive growth, during the forecast period (20232032), mainly attributed to the launch of upcomi\u2026 [+14455 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Global Antibiotic Resistance Markets, 2023-2027: Beyond Antibiotics - Exploring Cutting-Edge Trends in AMR Solutions",
            "description": "Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The \"Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides & Customization. 2023 to 2027\" report has been added to ResearchAndMarkets.com's off\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/05/2755212/28124/en/Global-Antibiotic-Resistance-Markets-2023-2027-Beyond-Antibiotics-Exploring-Cutting-Edge-Trends-in-AMR-Solutions.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-10-05T10:43:00Z",
            "content": "Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The \"Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive &amp; Investor Guides &amp; Customization.\u2026 [+7208 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Publicnow",
            "title": "ENLIVEX THERAPEUTICS : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K",
            "description": "(marketscreener.com) \n ENLIVEX THERAPEUTICS LTD.\n \n \n NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS\n \n \n To be held on October 26, 2023\n \n \n Dear Shareholder:\n \n \n We cordially invite you to attend the Annual General Meeting of Shareholders of Enlivex Ther\u2026",
            "url": "https://www.marketscreener.com/quote/stock/ENLIVEX-THERAPEUTICS-LTD-56422776/news/ENLIVEX-THERAPEUTICS-NOTICE-OF-ANNUAL-GENERAL-MEETING-OF-SHAREHOLDERS-Form-6-K-44837421/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-09-13T20:45:04Z",
            "content": "ENLIVEX THERAPEUTICS LTD.\r\nNOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS\r\nTo be held on October 26, 2023\r\nDear Shareholder:\r\nWe cordially invite you to attend the Annual General Meeting of Shareho\u2026 [+69056 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "PRNewswire",
            "title": "GenScript Expands Range of Reagent Services, Adding Circular RNA and Lipid Nanoparticles Formulation",
            "description": "(marketscreener.com) \n\nBuilding on GenScript's fast and dependable in-vitro transcription mRNA synthesis service, GenScript now offers the most comprehensive range of RNA formats critical, enabling fast delivery of complex design for the research and developm\u2026",
            "url": "https://www.marketscreener.com/quote/stock/GENSCRIPT-BIOTECH-CORPORA-25502710/news/GenScript-Expands-Range-of-Reagent-Services-Adding-Circular-RNA-and-Lipid-Nanoparticles-Formulation-44864205/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-09-18T10:01:06Z",
            "content": "Building on GenScript's fast and dependable in-vitro transcription mRNA synthesis service, GenScript now offers the most comprehensive range of RNA formats critical, enabling fast delivery of complex\u2026 [+5803 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PR Newswire UK"
            },
            "author": null,
            "title": "Narcolepsy Market Analysis, Market Size, Epidemiology, and Competitive Analysis of Leading Companies Including Takeda, Suven Life Sciences Limited, Axsome Therapeutics, Inc., Avadel, and Others by DelveInsight",
            "description": "According to DelveInsight's' estimates, the narcolepsy market in the 7MM is expected to show good positive growth, during the forecast period (2023\u20132032), mainly attributed to new product launches, robust pipeline of emerging therapies, and improved diagnosis\u2026",
            "url": "https://www.prnewswire.co.uk/news-releases/narcolepsy-market-analysis-market-size-epidemiology-and-competitive-analysis-of-leading-companies-including-takeda-suven-life-sciences-limited-axsome-therapeutics-inc-avadel-and-others-by-delveinsight-301945232.html",
            "urlToImage": "https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg?p=facebook",
            "publishedAt": "2023-10-03T21:01:00Z",
            "content": "According to DelveInsight's' estimates, the narcolepsy market in the 7MM is expected to show good positive growth, during the forecast period (20232032), mainly attributed to new product launches, ro\u2026 [+11622 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Zion Market Research",
            "title": "Global Styrene Block Copolymers Market Growth Forecast: Surpassing USD 10.48 Billion by 2030 at 5.72% CAGR",
            "description": "[220 + Pages Research Study] According to a market research study published by Zion Market Research, the demand analysis of Global Styrene Block Copolymers Market size & share revenue was valued at around USD 6.72 billion in 2022 and is estimated to grow abou\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/15/2744001/0/en/Global-Styrene-Block-Copolymers-Market-Growth-Forecast-Surpassing-USD-10-48-Billion-by-2030-at-5-72-CAGR.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/1f4cf0ab-7d76-4136-a6dc-a5545f80f538",
            "publishedAt": "2023-09-15T12:48:00Z",
            "content": "New York, NY, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled Styrene Block Copolymers Market By Application (Footwear, Adhesives &amp; Sealants, Wi\u2026 [+17647 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Zion Market Research",
            "title": "Fabry Disease Treatment Market Size Projections Indicate a CAGR of 7.26%, Envisioned to Attain a Value of USD 3342.65 Million by 2030",
            "description": "[199+ Pages Study] According to a market research study published by Zion Market Research, the demand analysis of Global Fabry Disease Treatment Market size & share revenue was valued at around USD 1904.27 million in 2022 and is estimated to grow about USD 33\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/02/2753133/0/en/Fabry-Disease-Treatment-Market-Size-Projections-Indicate-a-CAGR-of-7-26-Envisioned-to-Attain-a-Value-of-USD-3342-65-Million-by-2030.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/1f4cf0ab-7d76-4136-a6dc-a5545f80f538",
            "publishedAt": "2023-10-02T20:01:00Z",
            "content": "NEW YORK, United States, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled Fabry Disease Treatment Market By Treatment (Substrate Reduction Therapy, En\u2026 [+16967 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "DelveInsight Business Research LLP",
            "title": "Diffuse Large B-cell Lymphoma Market to Show Immense Growth by 2032, Predicts DelveInsight | Leading Players to Look Out - AbbVie, Genmab, Merck, Xencor, Janssen, Roche, Biogen, Regeneron, Seagen, Takeda",
            "description": "The DLBCL market has a diverse pipeline, with the emergence of novel classes such as bi-specific antibodies, cancer vaccines, and allogeneic CAR-Ts in the third-line setting, whereas uptake of CD-19 targeted CART-Ts and CD79b targeted ADC is expected in the e\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/19/2745941/0/en/Diffuse-Large-B-cell-Lymphoma-Market-to-Show-Immense-Growth-by-2032-Predicts-DelveInsight-Leading-Players-to-Look-Out-AbbVie-Genmab-Merck-Xencor-Janssen-Roche-Biogen-Regeneron-Seag.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db",
            "publishedAt": "2023-09-19T17:00:00Z",
            "content": "New York, USA, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Diffuse Large B-cell Lymphoma Market to Show Immense Growth by 2032, Predicts DelveInsight | Leading Players to Look Out - AbbVie, Genmab, Merck, Xen\u2026 [+19636 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Future Market Insights Global and Consulting Pvt. Ltd.",
            "title": "Thyroid Function Test Market Thrives with a 4.2% CAGR, Predicted US$ 2.64 Billion by 2033 | Future Market Insights, Inc.",
            "description": "The United States is projected to dominate the thyroid function test market, with a 3.5% CAGR from 2023 to 2033. Government-funded endocrinology research and the growing obesity rates in young generations will drive market growth. The United States is project\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/11/2758346/0/en/Thyroid-Function-Test-Market-Thrives-with-a-4-2-CAGR-Predicted-US-2-64-Billion-by-2033-Future-Market-Insights-Inc.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/915d2f9c-7dc6-40c7-995c-2ba168208baa",
            "publishedAt": "2023-10-11T12:30:00Z",
            "content": "NEWARK, Del, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The thyroid function test market will be worth US$ 1.75 billion in 2023 and US$ 2.64 billion in 2033. Between 2023 and 2033, the market is expected to r\u2026 [+9017 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Liquidia Corporation",
            "title": "FDA Accepts Submission to Add PH-ILD to YUTREPIA\u2122 Label",
            "description": "MORRISVILLE, N.C., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (the Company) (NASDAQ: LQDA) announced today that the U.S. Food and Drug Administration (FDA) accepted for review the Company\u2019s amendment to the tentatively approved new drug applicati\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/25/2748984/0/en/FDA-Accepts-Submission-to-Add-PH-ILD-to-YUTREPIA-Label.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/e55e8861-ab9c-4e7d-9d8a-c12a3f16d631",
            "publishedAt": "2023-09-25T20:09:00Z",
            "content": "<ul><li>Sets PDUFA goal date of January 24, 2024</li><li>If approved, YUTREPIA would be indicated for treatment of both PAH and PH-ILD</li></ul>MORRISVILLE, N.C., Sept. 25, 2023 (GLOBE NEWSWIRE) -- L\u2026 [+8409 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Future Market Insights Global and Consulting Pvt. Ltd.",
            "title": "Renal Function Test Market Positioned for Impressive Business Expansion, Predicted to Achieve US$ 1,494.1 Million by 2033 with 5.5% CAGR | Future Market Insights, Inc.",
            "description": "Cutting-edge renal function test tech empowers CKD patients with at-home testing, promising streamlined processes, and global renal function test market revenue growth. Cutting-edge renal function test tech empowers CKD patients with at-home testing, promisin\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/05/2755376/0/en/Renal-Function-Test-Market-Positioned-for-Impressive-Business-Expansion-Predicted-to-Achieve-US-1-494-1-Million-by-2033-with-5-5-CAGR-Future-Market-Insights-Inc.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/915d2f9c-7dc6-40c7-995c-2ba168208baa",
            "publishedAt": "2023-10-05T12:30:00Z",
            "content": "NEWARK, Del: , Oct. 05, 2023 (GLOBE NEWSWIRE) -- According to a Future Market Insights (FMI) report, the renal function test market\u00a0is likely to hold a valuation of US$ 1,494.1 Million by 2033. As of\u2026 [+7945 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PR Newswire UK"
            },
            "author": null,
            "title": "Intrahepatic Cholangiocarcinoma Market to Grow Rapidly During the Study Period (2019-2032), Examines DelveInsight | Key Players - Virogin Biotech, Syndax, Delcath Systems, AstraZeneca, Amgen, Jazz, BeiGene",
            "description": "The dynamics of the intrahepatic cholangiocarcinoma market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness of the disease, incremental healthcare spending worldwide, and the expected laun\u2026",
            "url": "https://www.prnewswire.co.uk/news-releases/intrahepatic-cholangiocarcinoma-market-to-grow-rapidly-during-the-study-period-20192032-examines-delveinsight--key-players---virogin-biotech-syndax-delcath-systems-astrazeneca-amgen-jazz-beigene-301932940.html",
            "urlToImage": "https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-20T21:01:00Z",
            "content": "The dynamics of the intrahepatic cholangiocarcinoma market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness of the disease, incr\u2026 [+14011 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "SPHERICAL INSIGHTS LLP",
            "title": "Global Nanomedicine Market Size To Grow USD 564.15 Billion by 2032 | CAGR of 12.4%",
            "description": "The Global Nanomedicine Market Size was valued at USD 174.13 Billion in 2022 and the Worldwide Nanomedicine Market size is expected to reach USD 564.15 Billion by 2032, According to a research report published by Spherical Insights & Consulting. Companies Cov\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/18/2744575/0/en/Global-Nanomedicine-Market-Size-To-Grow-USD-564-15-Billion-by-2032-CAGR-of-12-4.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
            "publishedAt": "2023-09-18T10:30:00Z",
            "content": "New York, United States , Sept. 18, 2023 (GLOBE NEWSWIRE) -- The Global Nanomedicine Market Size is To Grow from USD 174.13 Billion in 2022 to USD 564.15 Billion by 2032, at a Compound Annual Growth \u2026 [+11777 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PR Newswire UK"
            },
            "author": null,
            "title": "Atherosclerotic Cardiovascular Disease Market to Observe Impressive Growth at a CAGR of 2.2% by 2032, Predicts DelveInsight",
            "description": "According to DelveInsight's' estimates, the atherosclerotic cardiovascular disease (ASCVD) market in the 7MM is expected to show positive growth, during the forecast period (2023\u20132032), mainly attributed to the launch of upcoming therapies and the increasing \u2026",
            "url": "https://www.prnewswire.co.uk/news-releases/atherosclerotic-cardiovascular-disease-market-to-observe-impressive-growth-at-a-cagr-of-2-2-by-2032--predicts-delveinsight-301939050.html",
            "urlToImage": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-26T21:01:00Z",
            "content": "According to DelveInsight's' estimates, the atherosclerotic cardiovascular disease (ASCVD) market in the 7MM is expected to show positive growth, during the forecast period (20232032), mainly attribu\u2026 [+14393 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PR Newswire UK"
            },
            "author": null,
            "title": "Parkinson's Disease Psychosis Market is Likely to Increase at a Steady Growth Rate by 2032, Estimates DelveInsight | Key Companies Working to Develop Therapies - Vanda, Kyowa Kirin, Sage, Athira, Aptinyx, CogState, AgeneBio",
            "description": "The dynamics of the Parkinson's disease psychosis market are anticipated to change in the coming years owing to the improvement in diagnosis methodologies, rising awareness of the disease, incremental healthcare spending worldwide, and the expected launch of \u2026",
            "url": "https://www.prnewswire.co.uk/news-releases/parkinsons-disease-psychosis-market-is-likely-to-increase-at-a-steady-growth-rate-by-2032-estimates-delveinsight--key-companies-working-to-develop-therapies---vanda-kyowa-kirin-sage-athira-aptinyx-cogstate-agenebio-301941336.html",
            "urlToImage": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook",
            "publishedAt": "2023-10-02T21:01:00Z",
            "content": "The dynamics of the Parkinson's disease psychosis market are anticipated to change in the coming years owing to the improvement in diagnosis methodologies, rising awareness of the disease, incrementa\u2026 [+13191 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "DelveInsight Business Research LLP",
            "title": "Chronic Obstructive Pulmonary Disease Market to Witness Upsurge in Growth During the Forecast Period (2023\u20132032), Assesses DelveInsight | Key Companies - Genentech, GlaxoSmithKline, Regeneron, Sanofi, AstraZeneca, Mereo, Inmunotek",
            "description": "The dynamics of the chronic obstructive pulmonary disease market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness of the disease, incremental healthcare spending worldwide, and the expecte\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/25/2748935/0/en/Chronic-Obstructive-Pulmonary-Disease-Market-to-Witness-Upsurge-in-Growth-During-the-Forecast-Period-2023-2032-Assesses-DelveInsight-Key-Companies-Genentech-GlaxoSmithKline-Regener.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db",
            "publishedAt": "2023-09-25T17:00:00Z",
            "content": "New York, USA, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Chronic Obstructive Pulmonary Disease Market to Witness Upsurge in Growth During the Forecast Period (20232032), Assesses DelveInsight | Key Companie\u2026 [+19682 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "Parkinson's Disease Psychosis Market is Likely to Increase at a Steady Growth Rate by 2032, Estimates DelveInsight | Key Companies Working to Develop Therapies - Vanda, Kyowa Kirin, Sage, Athira, Aptinyx, CogState, AgeneBio",
            "description": "The dynamics of the Parkinson's disease psychosis market are anticipated to change in the coming years owing to the improvement in diagnosis methodologies, rising awareness of the disease, incremental healthcare spending worldwide, and the expected launch of \u2026",
            "url": "https://www.prnewswire.com/news-releases/parkinsons-disease-psychosis-market-is-likely-to-increase-at-a-steady-growth-rate-by-2032-estimates-delveinsight--key-companies-working-to-develop-therapies---vanda-kyowa-kirin-sage-athira-aptinyx-cogstate-agenebio-301941331.html",
            "urlToImage": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook",
            "publishedAt": "2023-10-02T21:01:00Z",
            "content": "The dynamics of the Parkinson's disease psychosis market are anticipated to change in the coming years owing to the improvement in diagnosis methodologies, rising awareness of the disease, incrementa\u2026 [+13186 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "PDS Biotechnology Corporation",
            "title": "PDS Biotech to Present at the LD Micro Main Event XVI",
            "description": "PRINCETON, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech or the Company), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vacci\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/26/2749397/37149/en/PDS-Biotech-to-Present-at-the-LD-Micro-Main-Event-XVI.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/e2e7d124-dbd4-4140-9cc5-449d3488a902",
            "publishedAt": "2023-09-26T12:00:00Z",
            "content": "PRINCETON, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech or the Company), a clinical-stage immunotherapy company developing a growing pipeline of \u2026 [+6981 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Future Market Insights Global and Consulting Pvt. Ltd.",
            "title": "Increasing Prevalence of Cancer Driving Growth in Oncology Information Systems Market to reach US$ 5,828 Million by 2033; Growing at a 7.8% CAGR: Future Market Insights, Inc.",
            "description": "North America's regional oncology information systems market had the largest revenue share of 38.5%, with the United States forecasted to have a market share of 36%. The presence of sophisticated healthcare infrastructure and increased awareness about patient\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/19/2745858/0/en/Increasing-Prevalence-of-Cancer-Driving-Growth-in-Oncology-Information-Systems-Market-to-reach-US-5-828-Million-by-2033-Growing-at-a-7-8-CAGR-Future-Market-Insights-Inc.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/915d2f9c-7dc6-40c7-995c-2ba168208baa",
            "publishedAt": "2023-09-19T15:30:00Z",
            "content": "NEWARK, Del, Sept. 19, 2023 (GLOBE NEWSWIRE) -- The global oncology information systems market in 2022 was US$ 2593.4 million and is estimated to be US$ 2,753.8 million in 2023. Future Market Insight\u2026 [+7497 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Transparency Market Research",
            "title": "Clinical Trials Market to Exceed USD 83.5 billion by 2030, Garnering 5.4% CAGR \u2013 Exclusive Report by Transparency Market Research",
            "description": "The clinical trials market is expanding, driven by increased drug development activities and advancements in trial design and technology. The clinical trials market is expanding, driven by increased drug development activities and advancements in trial design\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/27/2750351/32656/en/Clinical-Trials-Market-to-Exceed-USD-83-5-billion-by-2030-Garnering-5-4-CAGR-Exclusive-Report-by-Transparency-Market-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/27b21b27-620b-4cae-8360-605a9662092b",
            "publishedAt": "2023-09-27T12:13:00Z",
            "content": "Wilmington, Delaware, United States, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The clinical trials market was estimated to have acquired US$ 46.7 billion in 2019. It is a\u2026 [+7821 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Global Vulvovaginal Candidiasis Treatment Market Report 2023: Drug Class, Route of Administration, Distribution Channel, Competition 2018-2028F",
            "description": "Dublin, Oct. 04, 2023 (GLOBE NEWSWIRE) -- The \"Vulvovaginal Candidiasis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Drug Class, By Route of Administration, By Distribution Channel, By Region and C\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/04/2754782/28124/en/Global-Vulvovaginal-Candidiasis-Treatment-Market-Report-2023-Drug-Class-Route-of-Administration-Distribution-Channel-Competition-2018-2028F.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-10-04T15:03:00Z",
            "content": "Dublin, Oct. 04, 2023 (GLOBE NEWSWIRE) -- The \"Vulvovaginal Candidiasis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Drug Class, By Route\u2026 [+6223 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Newsfilecorp",
            "title": "PharmaDrug Provides Development Update of Cepharanthine (PD-001) for Cancer and Infectious Disease",
            "description": "(marketscreener.com) PharmaDrug Inc. , is pleased to provide an update on the development activities of the Company's patented reformulated enteric coated version of orally bioavailable Cepharanthine as a potential treatment for oncology and infectious diseas\u2026",
            "url": "https://www.marketscreener.com/quote/stock/PHARMADRUG-INC-47103073/news/PharmaDrug-Provides-Development-Update-of-Cepharanthine-PD-001-for-Cancer-and-Infectious-Disease-44843681/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-09-14T12:05:01Z",
            "content": "Toronto, Ontario--(Newsfile Corp. - September 14, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) (\"PharmaDrug\" or the \"Company\"), is pleased to provide an update on the development activities of \u2026 [+10181 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Business Wire",
            "title": "Incyte to Present Multiple Studies from Dermatology Portfolio at 2023 European Academy of Dermatology and Venereology (EADV) Congress",
            "description": "(marketscreener.com) \nIncyte today announced multiple abstracts featuring new data from across its dermatology portfolio have been accepted for presentation at the upcoming European Academy of Dermatology and Venereology Congress 2023 held October 11-14 in Be\u2026",
            "url": "https://www.marketscreener.com/quote/stock/INCYTE-CORPORATION-9675/news/Incyte-to-Present-Multiple-Studies-from-Dermatology-Portfolio-at-2023-European-Academy-of-Dermatolog-44955828/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-09-29T17:44:01Z",
            "content": "Incyte (Nasdaq:INCY) today announced multiple abstracts featuring new data from across its dermatology portfolio have been accepted for presentation at the upcoming European Academy of Dermatology an\u2026 [+7908 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Incyte Announces Positive 52-Week Data from Phase 2b Study Evaluating Povorcitinib (INCB54707) in Patients with Extensive Nonsegmental Vitiligo",
            "description": "(marketscreener.com) \n- Longer-term use of povorcitinib resulted in further improvement in total body and facial repigmentation\n\n\n- Results were presented in a late-breaking news session at the European Academy of Dermatology and Venereology Congress 2023\n\nht\u2026",
            "url": "https://www.marketscreener.com/quote/stock/INCYTE-CORPORATION-9675/news/Incyte-Announces-Positive-52-Week-Data-from-Phase-2b-Study-Evaluating-Povorcitinib-INCB54707-in-Pa-45039733/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-10-11T12:17:01Z",
            "content": "- Longer-term use of povorcitinib resulted in further improvement in total body and facial repigmentation\r\n- Results were presented in a late-breaking news session at the European Academy of Dermatol\u2026 [+9752 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "DataHorizzon Research",
            "title": "DNA Synthesizer Market Size to Reach USD 971.6 Billion by 2032 CAGR: 14.6%. Report By DataHorizzon Research",
            "description": "According to DataHorizzon Research, The DNA synthesizer market\u00a0size was valued at USD 250.1 Billion in 2022 and is expected to have a market size of USD 971.6 Billion by 2032 with a CAGR of 14.6%. According to DataHorizzon Research, The DNA synthesizer market\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/25/2749093/0/en/DNA-Synthesizer-Market-Size-to-Reach-USD-971-6-Billion-by-2032-CAGR-14-6-Report-By-DataHorizzon-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/ee0903f0-279f-4537-8a89-666461d3d324",
            "publishedAt": "2023-09-25T23:50:00Z",
            "content": "Fort Collins, Colorado, Sept. 25, 2023 (GLOBE NEWSWIRE) -- DataHorizzon Research Published a report titled, \"DNA Synthesizer Market Size, Growth, Share, Statistics Report, By Product (Benchtop DNA Sy\u2026 [+11807 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PR Newswire UK"
            },
            "author": null,
            "title": "Head and Neck Squamous Cell Carcinoma Market to Witness Upsurge in Growth by 2032, Assesses DelveInsight | Key Companies in the Market - Pfizer, Merck, Eisai, AstraZeneca, Innate, Roche, GlaxoSmithKline, BeiGene, IO Biotech, Incyte",
            "description": "The dynamics of the head and neck squamous cell carcinoma market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, incremental healthcare spending across the world, and the expected launch of emerging thera\u2026",
            "url": "https://www.prnewswire.co.uk/news-releases/head-and-neck-squamous-cell-carcinoma-market-to-witness-upsurge-in-growth-by-2032-assesses-delveinsight--key-companies-in-the-market---pfizer-merck-eisai-astrazeneca-innate-roche-glaxosmithkline-beigene-io-biotech-incyt-301930338.html",
            "urlToImage": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-18T21:01:00Z",
            "content": "The dynamics of the head and neck squamous cell carcinoma market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, incremental healthcare spending\u2026 [+15108 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "Head and Neck Squamous Cell Carcinoma Market to Witness Upsurge in Growth by 2032, Assesses DelveInsight | Key Companies in the Market - Pfizer, Merck, Eisai, AstraZeneca, Innate, Roche, GlaxoSmithKline, BeiGene, IO Biotech, Incyte",
            "description": "The dynamics of the head and neck squamous cell carcinoma market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, incremental healthcare spending across the world, and the expected launch of emerging thera\u2026",
            "url": "https://www.prnewswire.com/news-releases/head-and-neck-squamous-cell-carcinoma-market-to-witness-upsurge-in-growth-by-2032-assesses-delveinsight--key-companies-in-the-market---pfizer-merck-eisai-astrazeneca-innate-roche-glaxosmithkline-beigene-io-biotech-incyt-301930322.html",
            "urlToImage": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-18T21:01:00Z",
            "content": "The dynamics of the head and neck squamous cell carcinoma market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, incremental healthcare spending\u2026 [+15103 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "Cryo-electron Microscopy Market Size Envisaged to Reach USD 3.41 Billion By 2032, at a CAGR of 11.4%: Polaris Market Research",
            "description": "NEW YORK, Sept. 22, 2023 /PRNewswire/ -- A latest research report [115+] pages with 360-Degree visibility, titled \"Cryo-electron Microscopy Market Share, Size, Trends, Industry Analysis Report, By Product (Software, Services, Instrument); By Technology; By Ap\u2026",
            "url": "https://www.prnewswire.com/news-releases/cryo-electron-microscopy-market-size-envisaged-to-reach-usd-3-41-billion-by-2032--at-a-cagr-of-11-4-polaris-market-research-301936116.html",
            "urlToImage": "https://mma.prnewswire.com/media/1316207/Polaris_Market_Research_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-22T14:01:00Z",
            "content": "NEW YORK, Sept. 22, 2023 /PRNewswire/ -- A latest research report [115+] pages with 360-Degree visibility, titled\u00a0\"Cryo-electron Microscopy Market Share, Size, Trends, Industry Analysis Report, By Pr\u2026 [+13127 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Business Wire",
            "title": "Starton Therapeutics Announces the Opening of the First Clinical Site for STAR-LLD Lenalidomide Phase 1b Trial in Multiple Myeloma",
            "description": "(marketscreener.com) \n\nGabrail Cancer & Research Center activated and open to screen patients, with Nash Gabrail, MD as lead investigator\n\n\n\nSite activation comes several months ahead of schedule, significantly accelerating Starton\u2019s clinical program timeline\u2026",
            "url": "https://www.marketscreener.com/quote/stock/HEALTHWELL-ACQUISITION-CO-127356958/news/Starton-Therapeutics-Announces-the-Opening-of-the-First-Clinical-Site-for-STAR-LLD-Lenalidomide-Phas-44837116/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-09-13T20:06:02Z",
            "content": "Gabrail Cancer &amp; Research Center activated and open to screen patients, with Nash Gabrail, MD as lead investigator\r\nSite activation comes several months ahead of schedule, significantly accelerat\u2026 [+16409 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "DataHorizzon Research",
            "title": "Cell Therapy Market Size to Reach USD 23.1 Billion By 2032 CAGR: 16.8%. Report By DataHorizzon Research",
            "description": "According to DataHorizzon Research, The cell therapy market size was USD 4.9 Billion in 2022 and is projected to grow to USD 23.1 Billion by 2032 with a CAGR of 16.8%. According to DataHorizzon Research, The cell therapy market size was USD 4.9 Billion in 202\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/26/2749094/0/en/Cell-Therapy-Market-Size-to-Reach-USD-23-1-Billion-By-2032-CAGR-16-8-Report-By-DataHorizzon-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/ee0903f0-279f-4537-8a89-666461d3d324",
            "publishedAt": "2023-09-26T00:00:00Z",
            "content": "Fort Collins, Colorado, Sept. 25, 2023 (GLOBE NEWSWIRE) -- DataHorizzon Research Published a report titled, \"Cell Therapy Market Size, Trends, Growth, Share, Statistics Analysis Report, By Cell Type,\u2026 [+11175 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "PDS Biotechnology Corporation",
            "title": "PDS Biotech Reschedules Key Opinion Leader Roundtable Addressing Current and Future Treatments for Recurrent/Metastatic HPV-Positive HNSCC and the Potential Application of PDS0101",
            "description": "PRINCETON, N.J., Sept. 25, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech or the Company), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vacci\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/25/2748603/37149/en/PDS-Biotech-Reschedules-Key-Opinion-Leader-Roundtable-Addressing-Current-and-Future-Treatments-for-Recurrent-Metastatic-HPV-Positive-HNSCC-and-the-Potential-Application-of-PDS0101.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/e2e7d124-dbd4-4140-9cc5-449d3488a902",
            "publishedAt": "2023-09-25T12:00:00Z",
            "content": "<ul><li>Event to be held on Tuesday, October 3 from 8:00 to 9:00 AM EDT</li></ul>PRINCETON, N.J., Sept. 25, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech or the C\u2026 [+7860 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "PDS Biotechnology Corporation",
            "title": "PDS Biotech to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference",
            "description": "PRINCETON, N.J., Sept. 20, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech or the Company), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vacci\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/20/2746844/37149/en/PDS-Biotech-to-Participate-in-the-2023-Cantor-Fitzgerald-Global-Healthcare-Conference.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/e2e7d124-dbd4-4140-9cc5-449d3488a902",
            "publishedAt": "2023-09-20T20:05:00Z",
            "content": "PRINCETON, N.J., Sept. 20, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech or the Company), a clinical-stage immunotherapy company developing a growing pipeline of \u2026 [+7210 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "New Long-Term Data from Incyte Phase 3 TRuE-V Program Demonstrates Efficacy of Continued Treatment with Opzelura\u00ae (Ruxolitinib) Cream in Nonsegmental Vitiligo Patients",
            "description": "(marketscreener.com) \n- Patients who initially experienced limited or no facial or total body repigmentation at six months achieved improved repigmentation after continued treatment with Opzelura for up to two years\n\n\n- Results were presented in a late-breaki\u2026",
            "url": "https://www.marketscreener.com/quote/stock/INCYTE-CORPORATION-9675/news/New-Long-Term-Data-from-Incyte-Phase-3-TRuE-V-Program-Demonstrates-Efficacy-of-Continued-Treatment-w-45041220/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-10-11T14:31:01Z",
            "content": "- Patients who initially experienced limited or no facial or total body repigmentation at six months achieved improved repigmentation after continued treatment with Opzelura for up to two years\r\n- Re\u2026 [+16279 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Zion Market Research",
            "title": "Global Cardiac Arrest Treatment Market: Forecasted Growth to Reach USD 8.3 Billion by 2030, At a CAGR of 4.5%",
            "description": "[228 + Pages Report] According to a market research study published by Zion Market Research, the demand analysis of Global Cardiac Arrest Treatment Market size & share revenue was valued at around USD 5 billion in 2022 and is estimated to grow about USD 8.3 b\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/02/2753208/0/en/Global-Cardiac-Arrest-Treatment-Market-Forecasted-Growth-to-Reach-USD-8-3-Billion-by-2030-At-a-CAGR-of-4-5.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/1f4cf0ab-7d76-4136-a6dc-a5545f80f538",
            "publishedAt": "2023-10-02T21:29:00Z",
            "content": "NEW YORK, United States, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled Cardiac Arrest Treatment Market By Treatment (Drugs [Vasopressors, Anti-Arrh\u2026 [+16144 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Immuneering Presents Preclinical Data Demonstrating Encouraging Anti-Tumor Activity for IMM-1-104 and IMM-6-415 at AACR-NCI-EORTC Conference",
            "description": "(marketscreener.com) \u2013 Expanded benchmarking of IMM-1-104 as a single agent across more than 190 patient-aligned models in humanized 3D-tumor growth assays demonstrated high sensitivity in a wide range of MAPK-driven tumor types, including models of RAS and R\u2026",
            "url": "https://www.marketscreener.com/quote/stock/IMMUNEERING-CORPORATION-125277856/news/Immuneering-Presents-Preclinical-Data-Demonstrating-Encouraging-Anti-Tumor-Activity-for-IMM-1-104-an-45053402/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-10-12T20:06:02Z",
            "content": "Expanded benchmarking of IMM-1-104 as a single agent across more than 190 patient-aligned models in humanized 3D-tumor growth assays demonstrated high sensitivity in a wide range of MAPK-driven tumor\u2026 [+12280 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Vivos Therapeutics, Inc",
            "title": "Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark\u2122 Clear Aligners to Its National Network of Providers",
            "description": "New Relationships Expected to Add Potentially Significant New Revenue Opportunities for Vivos as well as Airway-Focused Expertise and Potential Cost Savings for Vivos-trained Providers New Relationships Expected to Add Potentially Significant New Revenue Oppo\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/04/2754469/0/en/Vivos-Therapeutics-Executes-Strategic-Agreements-with-Ormco-and-On-Demand-Orthodontist-To-Provide-Spark-Clear-Aligners-to-Its-National-Network-of-Providers.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/22d07f60-2e17-421d-bbc3-748c2402061e",
            "publishedAt": "2023-10-04T11:30:00Z",
            "content": "LITTLETON, Colo., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the Company or Vivos) (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and \u2026 [+8260 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Straits Research",
            "title": "Proteomics Market Size is projected to Grow at a 12.5% CAGR by 2030, Driven by pioneering breakthroughs in analyzing protein interactions",
            "description": "Proteomics has made significant progress toward its goal of developing personalized medicine due to the tremendous advances made in studying protein interactions, protein expression patterns, modifications, and translation techniques. As a result, the proteom\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/12/2759596/0/en/Proteomics-Market-Size-is-projected-to-Grow-at-a-12-5-CAGR-by-2030-Driven-by-pioneering-breakthroughs-in-analyzing-protein-interactions.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/c25b8e5a-9a9f-499a-8eb6-76ff0d860959",
            "publishedAt": "2023-10-12T18:10:00Z",
            "content": "New York, United States, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Proteomics refers to the all-encompassing study of proteins. The field of proteomics searches for proteins associated with disease and inves\u2026 [+6877 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "Plasma Fractionation Market: United States Dominates as the Hub of Plasma Collection Centers, Asia-Pacific Shows Promising Growth",
            "description": "DUBLIN, Oct. 2, 2023 /PRNewswire/ -- The \"Plasma Fractionation Market by Type of Company, Scale of Operation, Type of Plasma-derived Therapeutic Products Manufactured, Therapeutic Areas of Plasma-derived Products and Key Geographical Regions: Industry Trends \u2026",
            "url": "https://www.prnewswire.com/news-releases/plasma-fractionation-market-united-states-dominates-as-the-hub-of-plasma-collection-centers-asia-pacific-shows-promising-growth-301944265.html",
            "urlToImage": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook",
            "publishedAt": "2023-10-02T15:00:00Z",
            "content": "DUBLIN, Oct. 2, 2023 /PRNewswire/ -- The\u00a0\"Plasma Fractionation Market by Type of Company, Scale of Operation, Type of Plasma-derived Therapeutic Products Manufactured, Therapeutic Areas of Plasma-der\u2026 [+9373 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Transparency Market Research",
            "title": "Hernia Repair Devices Market Revenue to Cross USD 8.62 billion by 2031 \u2013 Exclusive Report by Transparency Market Research",
            "description": "The rise in cases and the demand for effective treatment are expected to boost demand for hernia repair devices. The rise in cases and the demand for effective treatment are expected to boost demand for hernia repair devices.",
            "url": "https://www.globenewswire.com/news-release/2023/09/29/2751862/32656/en/Hernia-Repair-Devices-Market-Revenue-to-Cross-USD-8-62-billion-by-2031-Exclusive-Report-by-Transparency-Market-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/27b21b27-620b-4cae-8360-605a9662092b",
            "publishedAt": "2023-09-29T10:36:00Z",
            "content": "Wilmington, Delaware, United States, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The hernia repair devices market was valued at US$ 5.5 billion in 2020. The hernia repair d\u2026 [+7359 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Global Ophthalmic Drug Delivery System Market Drivers, Restraints, Opportunities and Challenges 2023-2030",
            "description": "Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The \"Global Ophthalmic Drug Delivery System Market by Technology, Production Technology, Material, Delivery Route - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast 2023-2030\" rep\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/25/2748606/28124/en/Global-Ophthalmic-Drug-Delivery-System-Market-Drivers-Restraints-Opportunities-and-Challenges-2023-2030.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-09-25T12:03:00Z",
            "content": "Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The \"Global Ophthalmic Drug Delivery System Market by Technology, Production Technology, Material, Delivery Route - Cumulative Impact of COVID-19, Russia Uk\u2026 [+5196 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PR Newswire UK"
            },
            "author": null,
            "title": "A Comprehensive Analysis of the Chemotherapy-induced Complications Market Outlook by 2032 | DelveInsight",
            "description": "Cancer ranks as the second most common cause of death on a global scale, claiming the lives of 10 million individuals annually. Early screening, detection, and treatment measures have the potential to prevent at least one-third of all cancer-related deaths. L\u2026",
            "url": "https://www.prnewswire.co.uk/news-releases/a-comprehensive-analysis-of-the-chemotherapy-induced-complications-market-outlook-by-2032--delveinsight-301951670.html",
            "urlToImage": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook",
            "publishedAt": "2023-10-10T21:01:00Z",
            "content": "Cancer ranks as the second most common cause of death on a global scale, claiming the lives of 10 million individuals annually. Early screening, detection, and treatment measures have the potential t\u2026 [+20200 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Rising Prevalence of Rare Diseases Drives Demand for Plasma-Derived Therapies, Fueling Market Growth",
            "description": "Dublin, Oct. 02, 2023 (GLOBE NEWSWIRE) -- The \"Plasma Fractionation Market by Type of Company, Scale of Operation, Type of Plasma-derived Therapeutic Products Manufactured, Therapeutic Areas of Plasma-derived Products and Key Geographical Regions: Industry Tr\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/02/2752559/28124/en/Rising-Prevalence-of-Rare-Diseases-Drives-Demand-for-Plasma-Derived-Therapies-Fueling-Market-Growth.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-10-02T09:58:00Z",
            "content": "Dublin, Oct. 02, 2023 (GLOBE NEWSWIRE) -- The \"Plasma Fractionation Market by Type of Company, Scale of Operation, Type of Plasma-derived Therapeutic Products Manufactured, Therapeutic Areas of Plasm\u2026 [+9004 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Vantage Market Research",
            "title": "Life Sciences Tools Market Size & Share to Surpass $328.1 Billion by 2030 | Vantage Market Research",
            "description": "WASHINGTON, Sept. 22, 2023 (GLOBE NEWSWIRE) -- As per Vantage Market Research, the Life Sciences Tools market has witnessed significant growth in recent years due to technological advancements and increasing investments in research and development activities.\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/22/2747907/0/en/Life-Sciences-Tools-Market-Size-Share-to-Surpass-328-1-Billion-by-2030-Vantage-Market-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b992ad70-52a5-4308-9ec3-ec32ebfecaee",
            "publishedAt": "2023-09-22T11:35:00Z",
            "content": "WASHINGTON, Sept. 22, 2023 (GLOBE NEWSWIRE) -- As per Vantage Market Research, the Life Sciences Tools market has witnessed significant growth in recent years due to technological advancements and in\u2026 [+17218 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "DataHorizzon Research",
            "title": "Clear Aligners Market Size to Reach USD 118.8 Billion by 2032 | CAGR: 35.2% | DataHorizzon Research",
            "description": "Fort Collins, Colorado, Sept. 15, 2023 (GLOBE NEWSWIRE) -- DataHorizzon Research Published a report titled, \"Clear Aligners Market Size, Growth, Share, Statistics Report, By Age (Adults, Teens), By Material Type (Polyurethane, Plastic Polyethylene Terephthala\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/15/2743985/0/en/Clear-Aligners-Market-Size-to-Reach-USD-118-8-Billion-by-2032-CAGR-35-2-DataHorizzon-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/ee0903f0-279f-4537-8a89-666461d3d324",
            "publishedAt": "2023-09-15T12:30:00Z",
            "content": "Fort Collins, Colorado, Sept. 15, 2023 (GLOBE NEWSWIRE) -- DataHorizzon Research Published a report titled, \"Clear Aligners Market Size, Growth, Share, Statistics Report, By Age (Adults, Teens), By M\u2026 [+7746 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Business Wire",
            "title": "Starton Therapeutics Doses First Patient in Landmark STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma",
            "description": "(marketscreener.com) \n\nDosing comes three weeks after the first site opened\n\n\n\nFull enrollment of six patients is expected to take 10 months, conducted in up to three clinical sites\n\n\n\nMultiple readings for safety and efficacy are expected during the next 6 t\u2026",
            "url": "https://www.marketscreener.com/quote/stock/HEALTHWELL-ACQUISITION-CO-127356958/news/Starton-Therapeutics-Doses-First-Patient-in-Landmark-STAR-LLD-Lenalidomide-Phase-1b-Clinical-Trial-i-44981732/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-10-04T12:02:02Z",
            "content": "Dosing comes three weeks after the first site opened\r\nFull enrollment of six patients is expected to take 10 months, conducted in up to three clinical sites\r\nMultiple readings for safety and efficacy\u2026 [+17597 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "BelleTorus Corp.",
            "title": "ARPA-H Awards $3.5 Million Contract to BelleTorus Corp. (Belle.ai) to Expand Pediatric Healthcare Access Using Artificial Intelligence",
            "description": "ARPA-H awards $3.5 million contract to Belle.ai and UHP to develop an AI-driven pediatric telehealth solution for skin, ear, and throat conditions.......",
            "url": "https://www.globenewswire.com/news-release/2023/10/11/2758157/0/en/ARPA-H-Awards-3-5-Million-Contract-to-BelleTorus-Corp-Belle-ai-to-Expand-Pediatric-Healthcare-Access-Using-Artificial-Intelligence.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/cdd61020-4285-403d-b965-d061894150fe",
            "publishedAt": "2023-10-11T10:12:00Z",
            "content": "CAMBRIDGE, Mass., Oct. 11, 2023 (GLOBE NEWSWIRE) -- BelleTorus Corporation (Belle.ai) today announced that the Advanced Research Projects Agency for Health (ARPA-H) has awarded Belle.ai and its partn\u2026 [+6614 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "Human Microbiome Market size worth USD 1,689.5 Million, Globally, by 2027 at 21.8% CAGR: Verified Market Research\u00ae",
            "description": "The \"Global Human Microbiome Market Size By Product (Probiotic, Foods, Medical Foods), By Application (Therapeutics, Diagnostics), By Geographic Scope And Forecast\" report has been published by Verified Market Research\u00ae. The report provides an in-depth analys\u2026",
            "url": "https://www.prnewswire.com/news-releases/human-microbiome-market-size-worth-usd-1-689-5-million-globally-by-2027-at-21-8-cagr-verified-market-research-301937485.html",
            "urlToImage": "https://mma.prnewswire.com/media/2015407/VMR_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-25T14:45:00Z",
            "content": "The \"Global Human Microbiome Market Size By Product (Probiotic, Foods, Medical Foods), By Application (Therapeutics, Diagnostics), By Geographic Scope And Forecast\" report has been published by Verif\u2026 [+8241 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Incyte and Mandy Moore Partner to Empower People with Atopic Dermatitis to Find Their Moments of Clarity",
            "description": "(marketscreener.com) \nIncyte announced today its partnership with actress, singer and songwriter Mandy Moore on Moments of Clarity, an educational initiative highlighting the authentic stories of people living with mild to moderate atopic dermatitis and their\u2026",
            "url": "https://www.marketscreener.com/quote/stock/INCYTE-CORPORATION-9675/news/Incyte-and-Mandy-Moore-Partner-to-Empower-People-with-Atopic-Dermatitis-to-Find-Their-Moments-of-Cla-45040494/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-10-11T13:16:02Z",
            "content": "Incyte (Nasdaq:INCY) announced today its partnership with actress, singer and songwriter Mandy Moore on Moments of Clarity, an educational initiative highlighting the authentic stories of people livi\u2026 [+16598 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "Transcend Therapeutics and Yale awarded U.S. Department of Defense grant to study methylone for PTSD",
            "description": "Company also announces that the IMPACT-1 clinical trial is underway with open-label results expected in the coming months NEW YORK, Sept. 21, 2023 /PRNewswire/ -- Transcend Therapeutics, a biotechnology company developing rapid-acting treatments for neuropsyc\u2026",
            "url": "https://www.prnewswire.com/news-releases/transcend-therapeutics-and-yale-awarded-us-department-of-defense-grant-to-study-methylone-for-ptsd-301934974.html",
            "urlToImage": "https://mma.prnewswire.com/media/2217052/Transcend_Therapeutics_Logo_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-21T13:38:00Z",
            "content": "Company also announces that the IMPACT-1 clinical trial is underway with open-label results expected in the coming months\r\nNEW YORK, Sept. 21, 2023 /PRNewswire/ --\u00a0Transcend Therapeutics\r\n, a biotech\u2026 [+2489 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Antibodies Industry Poised for Remarkable Growth as Therapeutic Applications Expand Worldwide",
            "description": "Dublin, Sept. 15, 2023 (GLOBE NEWSWIRE) -- The \"Antibodies Market, By Drug Type, by Disease Indication By End User, And by Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030\" report has been added to ResearchAndMarkets.com's offering.",
            "url": "https://www.globenewswire.com/news-release/2023/09/15/2744056/28124/en/Antibodies-Industry-Poised-for-Remarkable-Growth-as-Therapeutic-Applications-Expand-Worldwide.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-09-15T13:43:00Z",
            "content": "Dublin, Sept. 15, 2023 (GLOBE NEWSWIRE) -- The \"Antibodies Market, By Drug Type, by Disease Indication By End User, And by Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030\" report\u2026 [+4420 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "PDS Biotechnology Corporation",
            "title": "PDS Biotech Announces PDS0202 Elicits Active Neutralization of Multiple Influenza Strains in Preclinical Studies",
            "description": "PRINCETON, N.J., Sept. 20, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech or the Company), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vacci\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/20/2746431/37149/en/PDS-Biotech-Announces-PDS0202-Elicits-Active-Neutralization-of-Multiple-Influenza-Strains-in-Preclinical-Studies.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/e2e7d124-dbd4-4140-9cc5-449d3488a902",
            "publishedAt": "2023-09-20T12:00:00Z",
            "content": "<ul><li>PDS0202 (Infectimune\u00ae + COBRA influenza antigens) vaccination also prevented illness/weight loss </li><li>Vaccine protected against replication of the virus in the lungs of ferrets after chal\u2026 [+11274 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Zion Market Research",
            "title": "Global Cell Culture Market Size to Exceed USD 8.75 Billion by 2030, At a CAGR 8.37% | Future of Biotechnology",
            "description": "[223 + Pages Report] According to a market research study published by Zion Market Research, the demand analysis of Global Cell Culture Market size & share revenue was valued at around USD 5.55 billion in 2022 and is estimated to grow about USD 8.75 billion b\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/26/2749134/0/en/Global-Cell-Culture-Market-Size-to-Exceed-USD-8-75-Billion-by-2030-At-a-CAGR-8-37-Future-of-Biotechnology.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/1f4cf0ab-7d76-4136-a6dc-a5545f80f538",
            "publishedAt": "2023-09-26T03:56:00Z",
            "content": "New York, NY, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled Cell Culture Market By Product (Consumables And Instruments), By Application (Biopharm\u2026 [+15456 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Transparency Market Research",
            "title": "Global Artificial Lift Systems Market is Anticipated to Reach US$ 12.3 Billion by 2027, Rising at a 5.0% CAGR: TMR Report",
            "description": "The increasing global energy demand, particularly in emerging economies, presents opportunities for the expansion of artificial lift systems in new markets The increasing global energy demand, particularly in emerging economies, presents opportunities for the\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/21/2747429/32656/en/Global-Artificial-Lift-Systems-Market-is-Anticipated-to-Reach-US-12-3-Billion-by-2027-Rising-at-a-5-0-CAGR-TMR-Report.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/27b21b27-620b-4cae-8360-605a9662092b",
            "publishedAt": "2023-09-21T14:23:00Z",
            "content": "Wilmington, Delaware, United States, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The artificial lift systems market was estimated to have acquired US$ 6.6 billion in 2018.\u00a0 It is anticipated to register a 5 %\u2026 [+10512 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Incyte Announces New Data for Ruxolitinib Cream (Opzelura\u00ae) in Children with Atopic Dermatitis",
            "description": "(marketscreener.com) \n- In the TRuE-AD3 trial, children with atopic dermatitis treated with ruxolitinib cream achieved significant efficacy, as defined by the Investigator\u2019s Global Assessment-treatment success , following eight weeks of treatment\n\n\n- In a sec\u2026",
            "url": "https://www.marketscreener.com/quote/stock/INCYTE-CORPORATION-9675/news/Incyte-Announces-New-Data-for-Ruxolitinib-Cream-Opzelura-in-Children-with-Atopic-Dermatitis-45061292/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-10-13T14:31:01Z",
            "content": "Incyte (Nasdaq:INCY) today announced expanded results from the pivotal Phase 3 TRuE-AD3 study evaluating the safety and efficacy of ruxolitinib cream (Opzelura\u00ae) in children (age 2 to &lt;12 years) w\u2026 [+20584 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "Intrahepatic Cholangiocarcinoma Market to Grow Rapidly During the Study Period (2019-2032), Examines DelveInsight | Key Players - Virogin Biotech, Syndax, Delcath Systems, AstraZeneca, Amgen, Jazz, BeiGene",
            "description": "The dynamics of the intrahepatic cholangiocarcinoma market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness of the disease, incremental healthcare spending worldwide, and the expected laun\u2026",
            "url": "https://www.prnewswire.com/news-releases/intrahepatic-cholangiocarcinoma-market-to-grow-rapidly-during-the-study-period-20192032-examines-delveinsight--key-players---virogin-biotech-syndax-delcath-systems-astrazeneca-amgen-jazz-beigene-301932934.html",
            "urlToImage": "https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-20T21:01:00Z",
            "content": "The dynamics of the intrahepatic cholangiocarcinoma market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness of the disease, incr\u2026 [+14007 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "TBRC Business Research PVT LTD",
            "title": "Cancer Immunotherapy Market Overview 2023-2027: Market Statistics, Prominent Trends, And Lucrative Segments As Per The Business Research Company's Cancer Immunotherapy Global Market Report 2023",
            "description": "The Business Research Company\u2019s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032 The Business Research Company\u2019s global market reports are now updated with the latest market sizing inform\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/02/2752960/0/en/Cancer-Immunotherapy-Market-Overview-2023-2027-Market-Statistics-Prominent-Trends-And-Lucrative-Segments-As-Per-The-Business-Research-Company-s-Cancer-Immunotherapy-Global-Market-R.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/3bf07720-8041-4b6e-84f3-8c3f28854315",
            "publishedAt": "2023-10-02T15:30:00Z",
            "content": "LONDON, Oct. 02, 2023 (GLOBE NEWSWIRE) -- As per The Business Research Companys Cancer Immunotherapy Global Market Report 2023, the global cancer immunotherapy market is experiencing remarkable growt\u2026 [+5276 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "PDS Biotechnology Corporation",
            "title": "PDS Biotech Announces PDS0101 Combined with Chemoradiotherapy Associated with Rapid Decline in Circulating Tumor DNA (ctDNA/cfDNA)",
            "description": "PRINCETON, N.J., Oct. 02, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech or the Company), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccin\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/02/2752689/37149/en/PDS-Biotech-Announces-PDS0101-Combined-with-Chemoradiotherapy-Associated-with-Rapid-Decline-in-Circulating-Tumor-DNA-ctDNA-cfDNA.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/e2e7d124-dbd4-4140-9cc5-449d3488a902",
            "publishedAt": "2023-10-02T12:00:00Z",
            "content": "<ul><li>Study evaluated levels of circulating cell-free HPV DNA (cfDNA) in patients with locally advanced cervical cancer in the IMMUNOCERV Phase 2 clinical trial and patients receiving standard of c\u2026 [+12416 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "PDS Biotechnology Corporation",
            "title": "PDS Biotech Announces Interim 24-Month Survival Rate of 74% in Immune Checkpoint Inhibitor Na\u00efve Head and Neck Cancer Patients Treated with PDS0101 in Combination with KEYTRUDA\u00ae (pembrolizumab)",
            "description": "PRINCETON, N.J., Oct. 03, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech or the Company), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccin\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/03/2753452/37149/en/PDS-Biotech-Announces-Interim-24-Month-Survival-Rate-of-74-in-Immune-Checkpoint-Inhibitor-Na%C3%AFve-Head-and-Neck-Cancer-Patients-Treated-with-PDS0101-in-Combination-with-KEYTRUDA-pemb.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/e2e7d124-dbd4-4140-9cc5-449d3488a902",
            "publishedAt": "2023-10-03T11:00:00Z",
            "content": "<ul><li>Interim VERSATILE-002 data for the first-line treatment of recurrent or metastatic head and neck cancer patients who were immune checkpoint inhibitor (ICI) na\u00efve; published 24-month survival \u2026 [+15098 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "CMI MARKET RESEARCH PRIVATE LIMITED",
            "title": "[Latest] Global Electromyography Devices Market Size/Share Worth USD 1658.9 Million by 2032 at a 8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)",
            "description": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Electromyography Devices Market size & share revenue was valued at approximately USD 789 Million in 2022 and is expected to reac\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/13/2742915/0/en/Latest-Global-Electromyography-Devices-Market-Size-Share-Worth-USD-1658-9-Million-by-2032-at-a-8-CAGR-Custom-Market-Insights-Analysis-Outlook-Leaders-Report-Trends-Forecast-Segment.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/74609d89-5437-4826-b7b8-31238ea2e65c",
            "publishedAt": "2023-09-13T22:30:00Z",
            "content": "Austin, TX, USA, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled Electromyography Devices Market Size, Trends and Insights By Product (Stationary \u2026 [+21310 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "GenScript Expands Range of Reagent Services, Adding Circular RNA and Lipid Nanoparticles Formulation",
            "description": "Building on GenScript's fast and dependable in-vitro transcription mRNA synthesis service, GenScript now offers the most comprehensive range of RNA formats critical, enabling fast delivery of complex design for the research and development of RNA vaccines and\u2026",
            "url": "https://www.prnewswire.com/news-releases/genscript-expands-range-of-reagent-services-adding-circular-rna-and-lipid-nanoparticles-formulation-301929911.html",
            "urlToImage": "https://mma.prnewswire.com/media/2213050/GenScript_circRNA_LNP_illustration.jpg?p=facebook",
            "publishedAt": "2023-09-18T10:00:00Z",
            "content": "\"Leveraging GenScript's cutting-edge gene synthesis technology and proprietary codon optimization algorithm, we are proud to offer the industry's first optimized, high-quality custom circRNA synthesi\u2026 [+4570 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Vantage Market Research",
            "title": "Label-free Detection Market Size & Share to Surpass $1058.4 Million by 2030 | Vantage Market Research",
            "description": "WASHINGTON, Sept. 25, 2023 (GLOBE NEWSWIRE) -- As per Vantage Market Research, the Label-free Detection Market experiences significant growth primarily fueled by technological advancements, increasing collaboration between academic and industrial entities in \u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/25/2748519/0/en/Label-free-Detection-Market-Size-Share-to-Surpass-1058-4-Million-by-2030-Vantage-Market-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b992ad70-52a5-4308-9ec3-ec32ebfecaee",
            "publishedAt": "2023-09-25T11:14:00Z",
            "content": "WASHINGTON, Sept. 25, 2023 (GLOBE NEWSWIRE) -- As per Vantage Market Research, the Label-free Detection Market experiences significant growth primarily fueled by technological advancements, increasin\u2026 [+20154 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Gizmodo.com"
            },
            "author": "Ed Cara",
            "title": "After First Setback, Second Pig Heart Transplant Provokes Cautious Optimism",
            "description": "58-year-old Lawrence Faucette has become a medical milestone this month, being only the second living person in the world to have received a heart transplant from a genetically modified pig. Read more...",
            "url": "https://gizmodo.com/second-pig-heart-transplant-xenotransplantation-1850882690",
            "urlToImage": "https://i.kinja-img.com/gawker-media/image/upload/c_fill,f_auto,fl_progressive,g_center,h_675,pg_1,q_80,w_1200/9b66cf69c422016e8a12f8c604700883.jpg",
            "publishedAt": "2023-09-28T16:59:00Z",
            "content": "58-year-old Lawrence Faucette has become a medical milestone this month, being only the second living person in the world to have received a heart transplant from a genetically modified pig. \r\nHis do\u2026 [+4839 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "Precision Biologics Announces the United States Patent and Trademark Office (USPTO) has granted a Patent for its Lead Monoclonal Antibody, NEO-201, For the Treatment of Human Carcinomas",
            "description": "BETHESDA, Md., Oct. 2, 2023 /PRNewswire/ -- Precision Biologics, Inc. (\"Precision\"), a clinical-stage immunotherapy and targeted oncology company, announced today that on September 26, 2023, the USPTO granted a patent for its lead clinical asset, NEO-201, whi\u2026",
            "url": "https://www.prnewswire.com/news-releases/precision-biologics-announces-the-united-states-patent-and-trademark-office-uspto-has-granted-a-patent-for-its-lead-monoclonal-antibody-neo-201-for-the-treatment-of-human-carcinomas-301944004.html",
            "urlToImage": null,
            "publishedAt": "2023-10-02T13:18:00Z",
            "content": "BETHESDA, Md., Oct. 2, 2023 /PRNewswire/ --\u00a0Precision Biologics, Inc. (\"Precision\"), a clinical-stage immunotherapy and targeted oncology company, announced today\u00a0that on September 26, 2023, the USPT\u2026 [+2686 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Visiongain Reports Ltd",
            "title": "Contract Research Organisations (CROs) market is projected to grow at a CAGR of 10.6% by 2033: Visiongain",
            "description": "Visiongain has published a new report entitled Contract Research Organisations (CROs) Market Report 2023-2033: Forecasts by Service (Preclinical, Clinical, Laboratory Services, Consulting Services, Data Management Services), by Therapeutic Area (Oncology, CNS\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/15/2744188/0/en/Contract-Research-Organisations-CROs-market-is-projected-to-grow-at-a-CAGR-of-10-6-by-2033-Visiongain.html",
            "urlToImage": "https://ml-eu.globenewswire.com/Resource/Download/6bdb779b-409b-453a-a1ac-5548f5b2a98e",
            "publishedAt": "2023-09-15T17:18:00Z",
            "content": "Visiongain has published a new report entitled Contract Research Organisations (CROs) Market Report 2023-2033: Forecasts by Service (Preclinical, Clinical, Laboratory Services, Consulting Services, D\u2026 [+11247 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "DataHorizzon Research",
            "title": "Sleep Apnea Devices Market Size to Reach USD 9.8 Billion By 2032 CAGR: 7.3%. Report By DataHorizzon Research",
            "description": "According to DataHorizzon Research, The sleep apnea devices market size was valued at USD 4.9 Billion in 2022 and is expected to reach a market size of USD 9.8 Billion by 2032 with a CAGR of 7.3%. According to DataHorizzon Research, The sleep apnea devices ma\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/25/2748296/0/en/Sleep-Apnea-Devices-Market-Size-to-Reach-USD-9-8-Billion-By-2032-CAGR-7-3-Report-By-DataHorizzon-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/ee0903f0-279f-4537-8a89-666461d3d324",
            "publishedAt": "2023-09-25T00:40:00Z",
            "content": "Fort Collins, Colorado, Sept. 24, 2023 (GLOBE NEWSWIRE) -- DataHorizzon Research Published a report titled, \"Sleep Apnea Devices Market Size, Trends, Growth, Share, Statistics Analysis Report By Diag\u2026 [+10487 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Coherent Market Insights Pvt. Ltd",
            "title": "Real-world Data (RWD) Market to reach $4.07 billion by 2030: Coherent Market Insights",
            "description": "Real-world data (RWD) refers to information derived from sources outside the realm of conventional clinical trials, gaining growing significance in contemporary healthcare decision-making processes. Real-world data (RWD) refers to information derived from sou\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/06/2756066/0/en/Real-world-Data-RWD-Market-to-reach-4-07-billion-by-2030-Coherent-Market-Insights.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/450ec960-647a-4b12-8885-a4afd6739e88",
            "publishedAt": "2023-10-06T12:18:00Z",
            "content": "Burlingame, Oct. 06, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global\u00a0real-world data (RWD) market is estimated to be valued at US$ 1.59 billion in 2023 and is expected to exhib\u2026 [+9821 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Precedence Research",
            "title": "Clinical Trial Supplies Market Size Will Reach USD 4.9\u00a0Bn by 2032",
            "description": "According to precedence research,\u00a0the clinical trial supplies market is expected to grow at an 6.51% CAGR from 2023\u00a0to 2023, reaching USD 4.9\u00a0billion by 2032. According to precedence research,\u00a0the clinical trial supplies market is expected to grow at an 6.51%\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/03/2753491/0/en/Clinical-Trial-Supplies-Market-Size-Will-Reach-USD-4-9-Bn-by-2032.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/501140d4-82c8-4a65-82a7-8466b5188635",
            "publishedAt": "2023-10-03T11:23:00Z",
            "content": "Ottawa, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The global clinical trial supplies market was valued at USD 2.61 billion in 2022. The major factors driving the growth of the clinical trial supplies market \u2026 [+10101 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Rationalstat LLC",
            "title": "Atopic Dermatitis Market 2023 \u2013 Uncovering Global Dynamics, Geographical Segmentation, and Forecast 2023-2030",
            "description": "The global atopic dermatitis market is expected to touch US$ 19.1 billion by 2030, with an annual growth rate of more than 8.7% The global atopic dermatitis market is expected to touch US$ 19.1 billion by 2030, with an annual growth rate of more than 8.7%",
            "url": "https://www.globenewswire.com/news-release/2023/10/12/2759225/0/en/Atopic-Dermatitis-Market-2023-Uncovering-Global-Dynamics-Geographical-Segmentation-and-Forecast-2023-2030.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/ced67b94-5d6b-4532-b365-e1f1f26f8f16",
            "publishedAt": "2023-10-12T12:15:00Z",
            "content": "Wilmington, Delaware, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Global \r\nAtopic Dermatitis\r\n Market\r\n value is estimated at US$ 10.7 billion in 2023 and is expected to grow at a significant CAGR of over 8.7%\u2026 [+10007 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Immuneering Corporation",
            "title": "Immuneering Presents Preclinical Data Demonstrating Encouraging Anti-Tumor Activity for IMM-1-104 and IMM-6-415 at AACR-NCI-EORTC Conference",
            "description": "\u2013 Expanded benchmarking of IMM-1-104 as a single agent across more than 190 patient-aligned models in humanized 3D-tumor growth assays demonstrated high sensitivity in a wide range of MAPK-driven tumor types, including models of RAS and RAF mutant melanoma, p\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/12/2759646/0/en/Immuneering-Presents-Preclinical-Data-Demonstrating-Encouraging-Anti-Tumor-Activity-for-IMM-1-104-and-IMM-6-415-at-AACR-NCI-EORTC-Conference.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/53f47482-3967-413c-b106-7062bb5140f7",
            "publishedAt": "2023-10-12T20:05:00Z",
            "content": "Expanded benchmarking of IMM-1-104 as a single agent across more than 190 patient-aligned models in humanized 3D-tumor growth assays demonstrated high sensitivity in a wide range of MAPK-driven tumor\u2026 [+12265 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Precedence Research",
            "title": "Protein Engineering Market Size is Expanding at USD 15.25 Billion by 2032",
            "description": "According to Precedence Research, the protein engineering market size was valued at USD 3.18 billion in 2022, and it is expanding at a CAGR of 16.97% over the forecast period 2023-2032. According to Precedence Research, the protein engineering market size was\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/11/2758518/0/en/Protein-Engineering-Market-Size-is-Expanding-at-USD-15-25-Billion-by-2032.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/501140d4-82c8-4a65-82a7-8466b5188635",
            "publishedAt": "2023-10-11T14:00:00Z",
            "content": "Ottawa, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The global protein engineering market size is projected to hit around USD 15.25 billion by 2032. Advancements in protein engineering technology, including ne\u2026 [+12716 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Arbutus Biopharma Corporation",
            "title": "Arbutus Announces Multiple Abstracts Accepted for Presentation at AASLD - The Liver Meeting\u00ae 2023",
            "description": "Imdusiran data will be highlighted in late breaking presentation      WARMINSTER, Pa., Oct.  11, 2023  (GLOBE NEWSWIRE) -- Arbutus Biopharma...",
            "url": "https://www.globenewswire.com/news-release/2023/10/11/2758327/14025/en/Arbutus-Announces-Multiple-Abstracts-Accepted-for-Presentation-at-AASLD-The-Liver-Meeting-2023.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/be474abd-3f6d-4270-a58e-1e6ee5c80bb2",
            "publishedAt": "2023-10-11T12:05:00Z",
            "content": "Imdusiran data will be highlighted in late breaking presentation\r\nWARMINSTER, Pa., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical c\u2026 [+12699 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Market.Us",
            "title": "Pain Management Devices Market Set to Soar to USD 9.4 Billion by 2032 || 8.1% CAGR - Opine Market.us Analysts",
            "description": "The expanding elderly population is contributing to the market's expansion since a significant portion of pain management device consumers consists of older individuals. The expanding elderly population is contributing to the market's expansion since a signif\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/10/2757639/0/en/Pain-Management-Devices-Market-Set-to-Soar-to-USD-9-4-Billion-by-2032-8-1-CAGR-Opine-Market-us-Analysts.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/80497cfc-1ece-42b4-9027-27841cdcb680",
            "publishedAt": "2023-10-10T13:34:00Z",
            "content": "New York, Oct. 10, 2023 (GLOBE NEWSWIRE) -- According to Market.us, the Pain Management Devices Market size is expected to be worth around USD 9.4 Billion by 2032 from USD 4.4 Billion in 2022, growin\u2026 [+12993 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Zion Market Research",
            "title": "Triple-Negative Breast Cancer Treatment Market Size to Surpass US$ 20 Billion by 2030",
            "description": "According to Zion Market Research, the global Triple-Negative Breast Cancer Treatment market size is projected to reach USD 20 billion by 2030 from its value of USD 11 billion in 2022, at a CAGR of 12.1% during the forecast period. According to Zion Market Re\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/25/2748957/0/en/Triple-Negative-Breast-Cancer-Treatment-Market-Size-to-Surpass-US-20-Billion-by-2030.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/1f4cf0ab-7d76-4136-a6dc-a5545f80f538",
            "publishedAt": "2023-09-25T18:45:00Z",
            "content": "NEW YORK, United States, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled Triple-Negative Breast Cancer Treatment Market\r\n By Drug Type (Cyclophospha\u2026 [+13121 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Market Reports World",
            "title": "Artificial Blood Market 2023 Rising Trends, Growing Demand and Regional Analysis and Forecast 2029",
            "description": "Pune, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Global Artificial Blood Market [2023-2029] Research Report Analysis and Outlook Insights |\u00a0Latest Updated Report\u00a0|\u00a089 Pages Report\u00a0| The Artificial Blood Market Size, Share, Growth, and Industry Analysis is Segmented b\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/26/2749380/0/en/Artificial-Blood-Market-2023-Rising-Trends-Growing-Demand-and-Regional-Analysis-and-Forecast-2029.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/f76f43b1-2795-46d0-981c-832a61a179b5",
            "publishedAt": "2023-09-26T11:38:00Z",
            "content": "Pune, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Global Artificial Blood Market [2023-2029] Research Report Analysis and Outlook Insights |\u00a0Latest Updated Report\u00a0|\u00a089 Pages Report\u00a0| The Artificial Blood Mark\u2026 [+13082 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "CAR T-cell Therapy for Multiple Myeloma Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key Companies - Cartesian, Arcellx, Novartis, Bristol-Myers Squibb, CARsgen, Poseida, Juno, CRISPR, bluebird bio",
            "description": "The relapsed/refractory multiple myeloma market landscape is undergoing a radical transformation with the recent FDA approvals of two CAR-Ts which is opening up new avenues for companies developing later lines of therapy. Several key players are racing to bri\u2026",
            "url": "https://www.prnewswire.com/news-releases/car-t-cell-therapy-for-multiple-myeloma-market-to-observe-stunning-growth-by-2032-evaluates-delveinsight--key-companies---cartesian-arcellx-novartis-bristol-myers-squibb-carsgen-poseida-juno-crispr-bluebird-bio-301937157.html",
            "urlToImage": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-25T21:01:00Z",
            "content": "The relapsed/refractory multiple myeloma market landscape is undergoing a radical transformation with the recent FDA approvals of two CAR-Ts which is opening up new avenues for companies developing l\u2026 [+17953 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "Atherosclerotic Cardiovascular Disease Market to Observe Impressive Growth at a CAGR of 2.2% by 2032, Predicts DelveInsight",
            "description": "According to DelveInsight's' estimates, the atherosclerotic cardiovascular disease (ASCVD) market in the 7MM is expected to show positive growth, during the forecast period (2023\u20132032), mainly attributed to the launch of upcoming therapies and the increasing \u2026",
            "url": "https://www.prnewswire.com/news-releases/atherosclerotic-cardiovascular-disease-market-to-observe-impressive-growth-at-a-cagr-of-2-2-by-2032--predicts-delveinsight-301939048.html",
            "urlToImage": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-26T21:01:00Z",
            "content": "According to DelveInsight's' estimates, the atherosclerotic cardiovascular disease (ASCVD) market in the 7MM is expected to show positive growth, during the forecast period (20232032), mainly attribu\u2026 [+14388 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Market.Us",
            "title": "Venous Stents Market to Reach USD 2.31 billion by 2032 | Amid Rising Demand From Hospitals and Cardiac Centers - Market.us",
            "description": "Positive reimbursement policies play a pivotal role in incentivizing healthcare providers to include venous stenting procedures in their services. The extent of reimbursement and the scope of coverage for venous stent interventions significantly impact both p\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/28/2751036/0/en/Venous-Stents-Market-to-Reach-USD-2-31-billion-by-2032-Amid-Rising-Demand-From-Hospitals-and-Cardiac-Centers-Market-us.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/80497cfc-1ece-42b4-9027-27841cdcb680",
            "publishedAt": "2023-09-28T10:53:00Z",
            "content": "New York, Sept. 28, 2023 (GLOBE NEWSWIRE) -- According Markte.us, The\u00a0Venous Stents market is estimated to be worth USD 1.02 Billion in 2022 and may attain USD 2.31 Billion by 2032. During the projec\u2026 [+12484 chars]"
        }
    ]
}